(photo by Anne Rayner)
Vern Schramm, Ph.D., shows his enthusiasm for protein transition states – the “in-between” stages of enzyme action – during his recent Discovery Lecture.
Schramm, the Ruth Merns Chair of the Department of Biochemistry at Albert Einstein College of Medicine, and his colleagues have used their studies to design powerful inhibitors now being tested in clinical trials as treatments for autoimmune diseases and several types of cancer.